ID4, a signature enriched for deletions (>1 bp) at repeats and microhomology, recently associated experimentally with TOP1 mutational activity in cancer and healthy cells,42 on the other hand was significantly more prevalent in non-high-risk patients (p < 1.68 × 10−3). The gene discussed is ID4; the disease is cancer.